Literature DB >> 17438069

A simple, no-wash cell adhesion-based high-throughput assay for the discovery of small-molecule regulators of the integrin CD11b/CD18.

Jun Y Park1, M Amin Arnaout, Vineet Gupta.   

Abstract

The leukocyte-specific integrin CD11b/CD18 plays a key role in the biological function of these cells and represents a validated therapeutic target for inflammatory diseases. Currently, the low affinity interaction between CD11b/CD18 integrin and its respective ligand poses a challenge in the development of cell-based adhesion assays for the high-throughput screening (HTS) environment. Here the authors describe a simple cell-based adhesion assay that can be readily used for HTS for the discovery of functional regulators of CD11b/CD18. The assay consistently produces acceptable Z' values (> 0.5) for HTS. After testing the assay using 2 established blocking antibodies as reference biologicals, the authors performed a proof-of-concept primary screen using a library of 6612 compounds and identified both agonist and antagonist hits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17438069      PMCID: PMC3075871          DOI: 10.1177/1087057106299162

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  42 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

Review 2.  Integrin structure: new twists and turns in dynamic cell adhesion.

Authors:  M Amin Arnaout
Journal:  Immunol Rev       Date:  2002-08       Impact factor: 12.988

3.  Distinct roles of Mac-1 and its counter-receptors in neonatal obstructive nephropathy.

Authors:  B Lange-Sperandio; K Schimpgen; B Rodenbeck; T Chavakis; A Bierhaus; P Nawroth; B Thornhill; F Schaefer; R L Chevalier
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

4.  Integrins and health.

Authors:  A F Horwitz
Journal:  Sci Am       Date:  1997-05       Impact factor: 2.142

5.  Peptides derived from the complementarity-determining regions of anti-Mac-1 antibodies block intercellular adhesion molecule-1 interaction with Mac-1.

Authors:  Y Feng; D Chung; L Garrard; G McEnroe; D Lim; J Scardina; K McFadden; A Guzzetta; A Lam; J Abraham; D Liu; G Endemann
Journal:  J Biol Chem       Date:  1998-03-06       Impact factor: 5.157

6.  Effect of integrin beta 2 subunit truncations on LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) assembly, surface expression, and function.

Authors:  S M Tan; R H Hyland; A Al-Shamkhani; W A Douglass; J M Shaw; S K Law
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

7.  Solvent-accessible residues on the metal ion-dependent adhesion site face of integrin CR3 mediate its binding to the neutrophil inhibitory factor.

Authors:  P Rieu; T Sugimori; D L Griffith; M A Arnaout
Journal:  J Biol Chem       Date:  1996-07-05       Impact factor: 5.157

8.  Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury.

Authors:  S G Soriano; A Coxon; Y F Wang; M P Frosch; S A Lipton; P R Hickey; T N Mayadas
Journal:  Stroke       Date:  1999-01       Impact factor: 7.914

9.  A novel form of integrin dysfunction involving beta1, beta2, and beta3 integrins.

Authors:  Alison McDowall; David Inwald; Birgit Leitinger; Alison Jones; Ri Liesner; Nigel Klein; Nancy Hogg
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

10.  Regulated expression of Mg2+ binding epitope on leukocyte integrin alpha subunits.

Authors:  I Dransfield; N Hogg
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

View more
  15 in total

1.  Opening the field of integrin biology to "biased agonism".

Authors:  Daniel I Simon
Journal:  Circ Res       Date:  2011-11-11       Impact factor: 17.367

2.  Small molecule agonist of very late antigen-4 (VLA-4) integrin induces progenitor cell adhesion.

Authors:  Peter Vanderslice; Ronald J Biediger; Darren G Woodside; Wells S Brown; Sayadeth Khounlo; Navin D Warier; C William Gundlach; Amy R Caivano; William G Bornmann; David S Maxwell; Bradley W McIntyre; James T Willerson; Richard A F Dixon
Journal:  J Biol Chem       Date:  2013-05-23       Impact factor: 5.157

3.  Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities In Vitro and In Vivo.

Authors:  Guangyong Ma; Jun-Ichirou Yasunaga; Koichi Ohshima; Tadashi Matsumoto; Masao Matsuoka
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

4.  High-throughput screening based identification of small molecule antagonists of integrin CD11b/CD18 ligand binding.

Authors:  Mohd Hafeez Faridi; Dony Maiguel; Brock T Brown; Eigo Suyama; Constantinos J Barth; Michael Hedrick; Stefan Vasile; Eduard Sergienko; Stephan Schürer; Vineet Gupta
Journal:  Biochem Biophys Res Commun       Date:  2010-02-25       Impact factor: 3.575

5.  Agonist leukadherin-1 increases CD11b/CD18-dependent adhesion via membrane tethers.

Authors:  Emrah Celik; Mohd Hafeez Faridi; Vinay Kumar; Shashank Deep; Vincent T Moy; Vineet Gupta
Journal:  Biophys J       Date:  2013-12-03       Impact factor: 4.033

6.  Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease.

Authors:  Dony Maiguel; Mohd Hafeez Faridi; Changli Wei; Yoshihiro Kuwano; Keir M Balla; Dayami Hernandez; Constantinos J Barth; Geanncarlo Lugo; Mary Donnelly; Ali Nayer; Luis F Moita; Stephan Schürer; David Traver; Phillip Ruiz; Roberto I Vazquez-Padron; Klaus Ley; Jochen Reiser; Vineet Gupta
Journal:  Sci Signal       Date:  2011-09-06       Impact factor: 8.192

7.  A Genetic Model of Constitutively Active Integrin CD11b/CD18.

Authors:  Laisel Martinez; Xiaobo Li; Gioser Ramos-Echazabal; Hafeez Faridi; Zachary M Zigmond; Nieves Santos Falcon; Diana R Hernandez; Serene A Shehadeh; Omaida C Velazquez; Vineet Gupta; Roberto I Vazquez-Padron
Journal:  J Immunol       Date:  2020-09-16       Impact factor: 5.422

8.  Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury.

Authors:  Mohd Hafeez Faridi; Mehmet M Altintas; Camilo Gomez; Juan Camilo Duque; Roberto I Vazquez-Padron; Vineet Gupta
Journal:  Biochim Biophys Acta       Date:  2013-02-26

9.  Identification of novel agonists of the integrin CD11b/CD18.

Authors:  Mohd Hafeez Faridi; Dony Maiguel; Constantinos J Barth; Darren Stoub; Ruth Day; Stephan Schürer; Vineet Gupta
Journal:  Bioorg Med Chem Lett       Date:  2009-10-22       Impact factor: 2.823

10.  Triple hybrids of steroids, spiroketals, and oligopeptides as new biomolecular chimeras.

Authors:  Abhisek Banerjee; Eduard Sergienko; Stefan Vasile; Vineet Gupta; Kristiina Vuori; Peter Wipf
Journal:  Org Lett       Date:  2009-01-01       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.